Portnoy Law Firm Announces Class Action On Behalf Of REGENXBIO, Inc. Investors

2026-02-19 10:46:34

(MENAFN- GlobeNewsWire - Nasdaq) LOS ANGELES, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises REGENXBIO, Inc., (“REGENXBIO” or the "Company") (NASDAQ: RGNX) investors of a class action on behalf of investors that bought securities between February 9, 2022 and January 27, 2026, inclusive (the“Class Period”). REGENXBIO investors have until April 14, 2026 to file a lead plaintiff motion.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: ..., to discuss their legal rights, or join the case via . The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses.

REGENXBIO is a clinical-stage biotechnology company that provides gene therapies that deliver functional genes to cells with genetic defects. REGENXBIO is developing product candidate RGX-111, a one-time gene therapy for the treatment of severe Mucopolysaccharidosis Type I (MPS I), also known as Hurler syndrome.

The REGENXBIO class action lawsuit alleges that defendants throughout the Class Period disseminated false and misleading statements and/or concealing material adverse facts concerning the efficacy and safety of its RGX-111 trial study.

The REGENXBIO investor class action lawsuit alleges that on January 28, 2026. REGENXBIO announced that the U.S. Food & Drug Administration placed a clinical hold on its investigational gene therapy RGX-111. In pertinent part, defendants allegedly announced that an intraventricular CNS tumor was found in a participant treated in its RGX-111 Phase I/II study. On this news, the price of REGENXBIO fell nearly 18%, according to the complaint.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
...
310-692-8883

Attorney Advertising

MENAFN19022026004107003653ID1110764040

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.